Advertisement

Receptor-Mediated Regulation of Cholesterol Metabolism

  • Robert W. Mahley
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)

Abstract

Cholesterol homeostasis is dependent on the action of specific lipoprotein receptors on various cells (especially within the liver) that mediate lipoprotein uptake and degradation. There are at least two distinct hepatic lipoprotein receptors: the apo-B,E(LDL) receptor and the apo-E receptor, which is postulated to be the chylomicron remnant receptor. They are independently regulated and display unique ligand specificity. In addition, the apo-B,E(LDL) and the apo-E receptors differ in apparent molecular weight (130,000 and 56,000, respectively). However, both receptors possess a region within their amino acid sequence that is enriched in acidic amino acids (glutamate and aspartate) and that is postulated to be the ligand-binding domain. The tentative identification of acidic amino acids within the receptors as being essential in mediating ligand interactions is based primarily on data showing that basic amino acids (lysine and arginine) of the ligands (apo E and apo B) mediate receptor binding. The receptor-binding domain of apo E has been localized to basic amino acids in the vicinity of residues 140 to 160. Naturally occurring variants of apo E with single amino acid substitutions in this region of the molecule are defective in their abilities to bind to the lipoprotein receptors and predispose affected individuals to develop type III hyperlipoproteinemia. Recently, it has been possible to define more clearly essential residues within this region of the apo E molecule by using site-specific mutagenesis. A natural extension of the studies defining the receptor-binding domain of apo E has been the identification of two basic regions of apo B that appear to mediate the interaction of this apolipoprotein with lipoprotein receptors. Eventually, it will be possible to develop a model describing ligand-receptor interactions; presumably, these occur through the interaction of key acidic amino acids of the receptors with the key basic amino acids of apo B and apo E.

Keywords

Basic Amino Acid Cholesterol Metabolism Lipoprotein Receptor Acidic Amino Acid Single Amino Acid Substitution 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Angelin, B., Raviola, C. A., Innerarity, T. L., and Mahley, R. W., 1983, Regulation of hepatic lipoprotein receptors in the dog. Rapid regulation of apolipoprotein B,E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids, J. Clin. Invest. 71:816–831.PubMedCrossRefGoogle Scholar
  2. Brown, M. S., and Goldstein, J. L., 1983, Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic, J. Clin. Invest. 72:743–747.PubMedCrossRefGoogle Scholar
  3. Brown, M. S., and Goldstein, J. L., 1986, A receptor-mediated pathway for cholesterol homeostasis, Science 232:34–47.PubMedCrossRefGoogle Scholar
  4. Hui, D. Y., Innerarity, T. L., and Mahley, R. W., 1981, Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors, J. Biol. Chem. 256:5646–5655.PubMedGoogle Scholar
  5. Hui, D. Y., Brecht, W. J., Hall, E. A., Friedman, G., Innerarity, T. L., and Mahley, R. W., 1986a, Isolation and characterization of the apolipoprotein E receptor from canine and human liver, J. Biol. Chem. 261:4256–4267.PubMedGoogle Scholar
  6. Hui, D. Y., Hall, E. A., Brecht, W. J., Innerarity, T. L., and Mahley, R. W., 1986b, Molecular cloning and identification of the ligand binding domain of the human apolipoprotein E receptor, Circulation 74:II-283.Google Scholar
  7. Innerarity, T. L., Kempner, E. S., Hui, D. Y., and Mahley, R. W., 1981, Functional unit of the low density lipoprotein receptor of fibroblasts: A 100,000-dalton structure with multiple binding sites, Proc. Natl. Acad. Sci. U.S.A. 78:4378–4382.PubMedCrossRefGoogle Scholar
  8. Innerarity, T. L., Friedlander, E. J., Rall, S. C., Jr., Weisgraber, K. H., and Mahley, R. W., 1983, The receptor binding domain of human apolipoprotein E: Binding of apolipoprotein E fragments, J. Biol. Chem. 258:12341–12347.PubMedGoogle Scholar
  9. Innerarity, T. L., Weisgraber, K. H., Arnold, K. S., Rall, S. C., Jr., and Mahley, R. W., 1984, Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation, J. Biol. Chem. 259:7261–7267.PubMedGoogle Scholar
  10. Knott, T. J., Rail, S. C., Jr., Innerarity, T. L., Jacobson, S. F., Urdea, M. S., Levy-Wilson, B., Powell, L. M., Pease, R. J., Eddy, R., Nakai, H., Byers, M., Priestley, L. M., Robertson, E., Rall, L. B., Betsholtz, C., Shows, T. B., Mahley, R. W., and Scott, J., 1985, Human apolipoprotein B: Structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization, Science 230:37–43.PubMedCrossRefGoogle Scholar
  11. Lalazar, A., Weisgraber, K. H., Giladi, H., Otter R. J., Innerarity, T. L., Vogel, T., and Mahley, R. W., 1986, Site-directed mutagenesis of the receptor binding domain of human apolipoprotein E, Circulation 74:II-283.Google Scholar
  12. Mahley, R. W., 1985, Atherogenic lipoproteins and coronary artery disease: Concepts derived from recent advances in cellular and molecular biology, Circulation 72:943–948.PubMedCrossRefGoogle Scholar
  13. Mahley, R. W., 1987, Biochemistry and physiology of lipid and lipoprotein metabolism, in: Principles and Practice of Endocrinology and Metabolism (C. R. Kahn and K. L. Becker, eds.), J. B. Lippincott, Philadelphia (in press).Google Scholar
  14. Mahley, R. W., and Innerarity, T. L., 1983, Lipoprotein receptors and cholesterol homeostasis, Biochim. Biophys. Acta 737:197–222.PubMedGoogle Scholar
  15. Mahley, R. W., Hui, D. Y., Innerarity, T. L., and Weisgraber, K. H., 1981, Two independent lipoprotein receptors on hepatic membranes of the dog, swine, and man. Apo-B,E and apo-E receptors, J. Clin. Invest. 68:1197–1206.PubMedCrossRefGoogle Scholar
  16. Mahley, R. W., Innerarity, T. L., Rall, S. C., Jr., and Weisgraber, K. H., 1984, Plasma lipoproteins: Apolipoprotein structure and function, J. Lipid Res. 25:1277–1294.PubMedGoogle Scholar
  17. Mahley, R. W., Innerarity, T. L., Rall, S. C., Jr., and Weisgraber, K. H., 1985, Lipoproteins of special significance in atherosclerosis: Insights provided by studies of type III hyperlipoproteinemia, Ann. N.Y. Acad. Sci. 454:209–221.PubMedCrossRefGoogle Scholar
  18. Pitas, R. E., Innerarity, T. L., Arnold, K. S., and Mahley, R. W., 1979, Rate and equilibrium constants for binding of apo-E HDLC (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: Evidence for multiple receptor binding of apo-E HDLc, Proc. Natl. Acad. Sci. U.S.A. 76:2311–2315.PubMedCrossRefGoogle Scholar
  19. Schneider, W. J., Beisiegel, U., Goldstein, J. L., and Brown, M. S., 1982, Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight, J. Biol. Chem. 257:2664–2673.PubMedGoogle Scholar
  20. Spilman, C. H., Corsini, A., Arnold, K., Boyles, J. K., Rall, S. C., Innerarity, T. L., and Mahley, R. W., 1986, Receptor binding of apo-B100 fragments recombined with inactivated apo-E HDLc, Circulation 74:11–106.Google Scholar
  21. Vogel, T., Weisgraber, K. H., Zeevi, M. I., Ben-Artzi, H., Levanon, A. Z., Rall, S. C., Jr., Innerarity, T. L., Hui, D. Y., Taylor, J. M., Kanner, D., Yavin, Z., Amit, B., Aviv, H., Gorecki, M., and Mahley, R. W., 1985, Human apolipoprotein E expression in Escherichia coli: Structural and functional identity of the bacterially produced protein with plasma apolipoprotein E, Proc. Natl. Acad. Sci. U.S.A. 82:8696–8700.PubMedCrossRefGoogle Scholar
  22. Weisgraber, K. H., Innerarity, T. L., Harder, K. J., Mahley, R. W., Milne, R. W., Marcel, Y. L., and Sparrow, J. T., 1983, The receptor binding domain of human apolipoprotein E: Monoclonal antibody inhibition of binding, J. Biol. Chem. 258:12348–12354.PubMedGoogle Scholar
  23. Weisgraber, K. H., Rall, S. C., Scott, J., Knott, T. J., and Mahley, R. W., 1986, Apolipoprotein B heparin binding sites: Insights into the receptor binding domain, Circulation 74:11–106.Google Scholar
  24. Yamamoto, T., Davis, C. G., Brown, M. S., Schneider, W. J., Casey, M. L., Goldstein, J. L., and Russell, D. W., 1984, The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA, Cell 39:27–38.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Robert W. Mahley
    • 1
    • 2
  1. 1.Gladstone Foundation Laboratories for Cardiovascular DiseaseCardiovascular Research InstituteUSA
  2. 2.Departments of Pathology and MedicineUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations